AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05592496 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Catheter insertion technique by using special tube t
Description: By using special tube, it is possible to locate the catheters in retromuscular space, where they are close to cutaneous nervs
Study NCT05592496 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Catheter insertion technique by using special tube t
Description: By using special tube, it is possible to locate the catheters in retromuscular space, where they are close to cutaneous nervs
Study NCT05592496 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Connection of catheters bilateraly to easy pump system,
Description: Connection of catheters, which are inserted in to retromuscular space, to ensure continuous receiving of Bupivacaine fluid for analgesia. Easy pump system provides continous receiving of bupivacaine fluid infusion speed - 5ml per hour
Study NCT05592496 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Connection of catheters bilateraly to easy pump system,
Description: Connection of catheters, which are inserted in to retromuscular space, to ensure continuous receiving of Bupivacaine fluid for analgesia. Easy pump system provides continous receiving of bupivacaine fluid infusion speed - 5ml per hour
Study NCT05592496 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: VAS scale for pain control
Description: By using Visual Analog scale of pains, the pain score is fixed
Study NCT05592496 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: VAS scale for pain control
Description: By using Visual Analog scale of pains, the pain score is fixed
Study NCT06190327 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Blended indoor and outdoor multicomponent structured exercise
Description: Participants will receive a 16-week blended indoor and outdoor multicomponent structured exercise program, with 2 sessions per week (90 mins/session). Session 1/week will conduct in indoor setting, while session 2/week will conducted in outdoor setting (park). Each session will comprise 10-min warm-up, 30-min aerobic training, 20-min muscle strength, 20-min postural balance training, and 10-min cool-down.
Study NCT06190327 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Indoor-only multicomponent structured exercise
Description: Participants will receive a 16-week indoor-only multicomponent structured exercise program, with 2 sessions per week (90 mins/session). Both two sessions will conducted in indoor setting. Each session will comprise 10-min warm-up, 30-min aerobic training, 20-min muscle strength, 20-min postural balance training, and 10-min cool-down.
Study NCT05440136 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3462817 (SC)
Description: Administered SC.
Study NCT05440136 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (SC)
Description: Administered SC.
Study NCT05440136 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3462817 (IV)
Description: Administered IV.
Study NCT05440136 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (IV)
Description: Administered IV.
Study NCT06252818 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ReHub
Description: ReHub provides support to rehabilitation professionals by offering information for the design, monitoring, and analysis of therapeutic exercise programs for respiratory functional rehabilitation.
Study NCT05682989 — intervention group
Intervention type: PROCEDURE
Intervention: Urodynamic investigations before and after a mesh surgery protocol.
Description: Urodynamic investigations (The urodynamic study included free uroflowmetry, postvoid residual, filling and voiding cystometry, and a urethral pressure profile. The filling cystometry and urethral pressure profile were performed with 37 degrees C normal saline similar to body temperature at an infusion rate of 80 ml/min.
Study NCT05682989 — intervention group
Intervention type: PROCEDURE
Intervention: Urodynamic investigations before and after a robotic-assisted sacrocolpopexy protocol.
Description: All surgeries were performed using a DaVinci robotic system (Intuitive® Surgical Inc., Sunnyvale, California,US) with standardized technique and materials. Patients were positioned in dorsal lithotomy and steep Trendelenburg position. Trocars were placed bilaterally, and an assistant port was placed laterally. The peritoneum was opened medial to the ureter to develop an avascular space. The mesh was placed on the posterior and anterior vaginal wall and fixed at the level of anterior longitudinal ligaments S1/S2 by sutures. An intraoperative clinical examination was performed to ensure the mesh was in a tension-free position.
Study NCT05682989 — intervention group
Intervention type: PROCEDURE
Intervention: Urodynamic investigations before and after a hysterectomy with trans-vaginal mesh repair
Description: In summary, a vertical incision was made in the anterior vaginal wall to access the vesicovaginal space. The sacrospinous ligament was dissected, and an applicator was inserted and positioned over the SSL. The anchor was fixed to the SSL and the thread was attached to the mesh. The mesh was then adjusted in a tension-free manner, excess mesh was cut, and the incision was closed with suture.
Study NCT04902664 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient education materials
Description: Patients receive a text-message and email with educational materials about medical testing.
Study NCT04902664 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physician peer-comparison email
Description: Physicians receive an email with feedback on how they compare to their peers in aggregate on test ordering during annual physicals.
Study NCT04902664 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physician education materials
Description: Physicians receive reference materials on medical test interpretation and incidental findings.
Study NCT04902664 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: General visit preparation materials
Description: Patients receive a text-message and email with general visit preparation tips.
Study NCT05320159 — intervention group
Intervention type: DRUG
Intervention: Secukinumab
Description: Included all the patients treated with secukinumab
Study NCT05348447 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care Pain Control
Description: Standard of Care Pain Control Post-operatively
Study NCT05616884 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cementless fixation
Description: Three dimensional printed porous metal, a biomaterial with morphological and mechanical properties that resemble those of native trabecular bone, is now being used for fixation of the tibial component in unicondylar knee arthroplasty. This can reliably achieve osseointegration into the tibia and could lead to a lower risk of aseptic loosening which is the leading cause of revision in partial knee replacements.
Study NCT05616884 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cementless fixation
Description: Three dimensional printed porous metal, a biomaterial with morphological and mechanical properties that resemble those of native trabecular bone, is now being used for fixation of the tibial component in unicondylar knee arthroplasty. This can reliably achieve osseointegration into the tibia and could lead to a lower risk of aseptic loosening which is the leading cause of revision in partial knee replacements.
Study NCT05021549 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: nasal prong
Description: apneic preoxygenation group (30 patients), will receive 10 L/ min of O2 via nasal prong during preintubation apnia
Study NCT05670392 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: laser and High intensity Tesla magnetic stimulation
Description: Three (3) non-ablative Er:YAG laser treatments will be applied at monthly intervals followed by Eight (8) HITS therapies) Patients will receive two (2) HITS treatments per week for four (4) weeks(.
Study NCT05670392 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: laser (without HITS treatment)
Description: Three (3) non-ablative Er:YAG laser treatments will be applied at monthly intervals as described above.
Study NCT05796765 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Micronized DHACM 40 mg
Description: Injection of 40 mg allogeneic micronized dehydrated human amnion chorion membrane (DHACM) suspended in 2.5 mL, 0.9% Sodium Chloride, USP
Study NCT05796765 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Micronized DHACM 100 mg
Description: Injection of 100 mg allogeneic micronized dehydrated human amnion chorion membrane (DHACM) suspended in 2.5 mL, 0.9% Sodium Chloride, USP
Study NCT05796765 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Injection of 2.5 ml, 0.9% Sodium Chloride, USP
Study NCT06486272 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Financial Navigator
Description: Intervention: Access to a Financial Navigator We anticipate the Financial Navigator will meet at least 2 times and up to 2 additional visits, at a time convenient for the family. Examples of financial services that will likely be offered by the Financial Navigator are tax filing, applying for benefits and financial counseling. The program will be flexible and family centered. Families can choose if they would like to meet the Financial Navigator in person at the NNFU appointment, during another medical appointment, or at another time during a virtual visit. The Financial Navigator will be integrated into the existing SickKids Resource Navigation Service. At the 18-month NNFU visit the study will be completed.
Study NCT06476158 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Kaiku Health
Description: Digital follow-up with Kaiku Health as medical device
Study NCT04761484 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vascular access on admission
Description: PIVC insertion
Study NCT03877653 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wireless neuromodulation
Description: A needle and catheter are carefully inserted near the enervated nerve. The stimulator is then placed through the catheter close to the nerve. The proximal end of the stimulator is then sutured underneath the skin to prevent migration.
Study NCT03877653 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Wireless neuromodulation
Description: A needle and catheter are carefully inserted near the enervated nerve. The stimulator is then placed through the catheter close to the nerve. The proximal end of the stimulator is then sutured underneath the skin to prevent migration.
Study NCT06013280 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progresive Muscle Relaxation and Breathing Exercise
Description: Intervention protocol contains 40 minuntes sessions, which involved tensing and relaxing the body along with deep breathing.~Protocol consisted with; Warm-up (5 minutes breathing exercise) Progressive Muscle Relaxation Exercises (The participants performed PMR for each body part in a particular order, beginning with the face muscles and head, followed by neck, shoulders, chest, abdomen, legs, and feet. This muscle tensing and relaxing procedures were performed in accompaniment with deep breathing.) Cool-down (5 minutes breathing exercise)
Study NCT05342337 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation Group
Description: The Telerehabilitation program includes a Biopsychosocial Exercise Therapy (BETY) approach.~BETY approach includes patient education on pain, functional body stabilization exercises (mind-body information management), dance therapy authentic movement (emotion-state information management), and sexual information management.~Telerehabilitation group participate in the sessions that last for one and a half hours, 3 days a week for 12 weeks, video conference over the Zoom program. The investigator, who provides supervision during the sessions, also participates in the exercises simultaneously.
Study NCT05342337 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: The control group participants include those who do not want to receive exercise treatment with telerehabilitation and take their routine medications during the 12 weeks period.
Study NCT06218706 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low Intensity Focussed Ultrasound
Description: The major objective of this study is to further test safety, tolerability, and feasibility of LIFU in this population as well as investigate the impact of LIFU on opioid and other substance use. The primary endpoint is 90 days (Post-LIFU Week 12) following Active/Sham LIFU. After the primary endpoint is reached, the blind will be broken and the group who received Sham LIFU will cross-over and receive Active LIFU
Study NCT06218706 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Low Intensity Focussed Ultrasound
Description: The major objective of this study is to further test safety, tolerability, and feasibility of LIFU in this population as well as investigate the impact of LIFU on opioid and other substance use. The primary endpoint is 90 days (Post-LIFU Week 12) following Active/Sham LIFU. After the primary endpoint is reached, the blind will be broken and the group who received Sham LIFU will cross-over and receive Active LIFU
Study NCT05260333 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Butterfly iQ transperineal ultrasound exam
Description: Transperineal ultrasound
Study NCT06246071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TYK-00540
Description: TYK-00540 PO, BID
Study NCT05251532 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesio Taping
Description: In addition to Kinesio Tex tape distortion taping, conventional rehabilitation is applied.
Study NCT05251532 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Rehabilitation
Description: Conventional rehabilitation practices are carried out
Study NCT06406803 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dietary energy restriction
Description: Patients enrolled in the dietary energy restriction group will reach an energy deficit of 40% only through reduced dietary intake.
Study NCT06406803 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Daily exercise
Description: Patients in the daily exercise group will reach an energy deficit of 40% through reduced dietary intake and increased physical activity (exercise).
Study NCT05692310 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: placing a standard central venous line
Description: Patients will benefit from the technique of central venous line placement by conventional ultrasound.
Study NCT05692310 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: placement of a central venous line using an ultraportable ultrasound device
Description: Patients will have a central venous line placed using an ultraportable ultrasound device
Study NCT05768243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Description: hyaluronic acid is used as an adjunctive treatment to scaling and root planing
Study NCT05768243 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: red injectable platelet rich fibrin (i-prf)
Description: injecting red i-prf into the pocket after scaling and root planing
Study NCT04489667 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: +STEP Implementation
Description: All patients receiving care at five RWHAP-funded clinics will receive the intervention (+STEP), in which patient-reported outcomes (PROs) on mental health and substance use disorder (SUD) will be integrated into routine care, targeted training will be provided for frontline clinicians on best practices for mental health and SUD treatment, and telemedicine for mental health and SUD will be offered to patients in need of expanded access to services.
Study NCT05569850 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Brushing
Description: Brushing the teeth 2x a day for 4 weeks.
Study NCT05569850 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Brushing
Description: Brushing the teeth 2x a day for 4 weeks.
Study NCT05406258 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Modified Self-Catheterization Mirror
Description: Following training, participants will have a modified mirror available for self-catheterization, as well as a standard, hospital-provided mirror. They will record the mirror used, position, and time for self-catheterization. They will also complete the System Usability Scale for each mirror related to self-operation and user satisfaction.
Study NCT05187793 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olokizumab
Description: Olokizumab, 128 mg, solution for subcutaneous administration 160 mg/mL
Study NCT05187793 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard therapy
Description: Standard treatment including:~* Baricitinib, 4 mg, film coated tablets~* Favipiravir, 200 mg, film coated tablets~* Dexamethasone IV or IM OR Methylprednisolone IV
Study NCT05187793 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard therapy
Description: Standard treatment including:~* Baricitinib, 4 mg, film coated tablets~* Favipiravir, 200 mg, film coated tablets~* Dexamethasone IV or IM OR Methylprednisolone IV
Study NCT04836728 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CIK cell injection
Description: CIK cells, more than 1x10\^10 (10 billion ), intravenous infusion,d14; Q3W.
Study NCT04836728 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab Injection
Description: Sintilimab Injection intravenous infusion 200mg d1
Study NCT04836728 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sintilimab Injection
Description: Sintilimab Injection intravenous infusion 200mg d1
Study NCT04836728 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Pemetrexed intravenous infusion 500mg/m2 d2
Study NCT04836728 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pemetrexed
Description: Pemetrexed intravenous infusion 500mg/m2 d2
Study NCT04836728 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albumin paclitaxel
Description: Albumin paclitaxel intravenous infusion 260mg/m2 d2
Study NCT04836728 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Albumin paclitaxel
Description: Albumin paclitaxel intravenous infusion 260mg/m2 d2
Study NCT04836728 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin intravenous infusion AUC5 d2
Study NCT04836728 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin intravenous infusion AUC5 d2
Study NCT04666233 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Neonatal resuscitation with PPE for the prevention of SARS-Cov-2 infection
Description: The team will perform neonatal resuscitation with PPE for the prevention of SARS-Cov-2 infection
Study NCT04666233 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Neonatal resuscitation without PPE for the prevention of SARS-Cov-2 infection
Description: The team will perform neonatal resuscitation without PPE for the prevention of SARS-Cov-2 infection
Study NCT05324995 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Multimodal Drug
Description: The Multimodal Drug group received morphine, epinephrine, and ketorolac (n=48), The epinephrine group (placebo group) (n=49) received 300 mcg epinephrine (1:1000) (DarouPakhsh, Tehran, Iran) peri-articulary,and the celecoxib group(control group)(n=49) recieved 400mg celecoxib orally
Study NCT05324995 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: epinephrine
Description: The second group received 300 mcg epinephrine (1:1000) (DarouPakhsh, Tehran, Iran) peri-articulary
Study NCT05324995 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: celecoxib
Description: The third group administered celecoxib (200 mg) orally immediately before the surgery
Study NCT05275764 — intervention group
Intervention type: PROCEDURE
Intervention: primary or secondary intraocular lens implantation surgery
Description: primary or secondary intraocular lens implantation surgery
Study NCT04791059 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S-ketamine
Description: S-ketamine 50 mg is included in the mixture for patient-controlled analgesia.
Study NCT04791059 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Dexmedetomidine 200 microgram is included in the mixture for patient-controlled analgesia.
Study NCT04791059 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sufentanil
Description: Sufentanil 4 microgram/kg (maximum 250 microgram) is included in the mixture for patient-controlled analgesia.
Study NCT04791059 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sufentanil
Description: Sufentanil 4 microgram/kg (maximum 250 microgram) is included in the mixture for patient-controlled analgesia.
Study NCT04969848 — intervention group
Intervention type: OTHER
Intervention: Wearable sensor
Description: IMU sensor (as part of eMSGait device) worn at the hip during T25FW
Study NCT06077370 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: deep TMS
Description: Deep Transcranial magnetic stimulation on anterior Cingulate cortex and medial prefrontal cortex. 20 Hz.
Study NCT06077370 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham TMS
Description: Sham Transcranial magnetic stimulation on anterior Cingulate cortex and medial prefrontal cortex. 20 Hz.